Clemens Bergwitz, MD
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Clemens W.H. Bergwitz, MD, is an endocrinologist at Yale Medicine who sees patients with primary hyperparathyroidism, general endocrine disorders, hyperthyroidism, thyroid nodules, adrenal disorder, hypophosphatemic disorders and hypogonadism.
Dr. Bergwitz’s characterizes the endocrine system as the human body’s own data messaging system. “It sends information to regulate some of our body’s most critical functions,” he says. In addition to treating patients, Dr. Bergwitz conducts research on many of these conditions, and his lab has worked on projects that test various therapies for hereditary endocrine disorders. “I am really a physician-scientist. My patients inspire my research, which eventually leads back to the bedside,” he says.
Dr. Bergwitz believes that patients should be the expert of their own illness. He strives to explain conditions and treatments in plain language so that patients not only understand their disorder, but also the biological mechanisms behind it. “I’m interested in providing my patients with the information they need to not only understand their condition, but to empower them to take good care of themselves,” he says.
Education & Training
- FellowshipMassachusetts General Hospital (2006)
- ResidencyMassachusetts General Hospital (2003)
- FellowshipNICHD, NIH (2001)
- ResidencyHannover Medical School (1999)
- Research FellowshipMassachusetts General Hospital and Harvard Medical School (1996)
- MDHannover Medical School (1993)
- BAWilhelm Gymnasium, Chemistry and Ancient Greek (1986)
Activities
- TIO and other causes of hypophosphatemiahttps://www.ese-hormones.org/events-deadlines/ese-events/early-bird-deadline-ese-clinical-update-on-calcium-and-bone-2022-online/ 2022European Society of Endocrinology Clinical Update on Calcium and Bone 2022 online webinar series
- Hereditary hypophosphataemic rickets with hypercalciuriaCalgary, AB, Canada 202219th Congress of the International Pediatric Nephrology Association (IPNA 2022)
- Phosphate-sensing and related skeletal disordersMarseille, Provence-Alpes-Côte d'Azur, France 2020Phosphate-sensing and related skeletal disorders
- Advances in FGF23 SignallingBrighton, England, United Kingdom 2018British Society for Endocrinology Annual Meeting
- Metabolic and endocrine sensing of phosphate – insights from genetic disordersNantes, Pays de la Loire, France 2017BBC2
- Disorders of Phosphate Homeostasis and Tissue MineralizationWürzburg, BY, Germany 2016International Expert Workshop on Rare Bone Diseases
- Phosphate Sensing: Two Sensors, a Metabolic and an Endocrine One?Atlanta, GA, United States 2016ASBMR 2016 Annual Meeting
- Genetic approaches to understanding phosphate homeostasis and Disorders of Phosphate Homeostasis and Tissue MineralizationDresden, SN, Germany 2015Endocrine Grand Rounds and Research Day
- Renal phosphaturia and SLC34A3 mutationsZürich, ZH, Switzerland 2009EUNEFRON
- Renal Sodium-Phosphate Cotransporters in Human DiseaseBethesda, MD, United States 2005NIH Inter-Institute Endocrine Grand Rounds, National Institute of Dental and Craniofacial Research, Craniofacial and Skeletal Diseases Branch, Bethesda, MD
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Yale Center for Clinical Investigation Pilot on "The impact of phosphate metabolism on healthy aging" | 2019 | |
O’Brien Center Pilot on “Role of Pyrophosphate in Nephrocalcinosis of Npt2a-/- Mice” | 2016, 2017, 2018 | |
Young Investigator Award on “Role of the renal sodium-phosphate cotransporter NaPi-IIc in phosphate homeostasis” | American Society for Clinical Investigation | 2007 |
Young Investigator Award on “Role of the renal sodium-phosphate cotransporter NaPi-IIc in phosphate homeostasis” | National Kidney Foundation | 2007 |
Von-Recklinghausen-Preis | German Endocrine Society | 1996 |
Professional Service
Organization | Role | Date |
---|---|---|
Gordon Conference on Physiology, Biology and Pathology of Phosphate | Session Chair | 2023 |
Barron's | Interview with Neal Templin from Barron's on what seniors can do to avoid osteoporosis: “Osteoporosis Affects Many. What to Know—and How to Prevent It.” | 2022 - Present |
Clinical Relevance of IV Iron-Associated Hypophosphatemia, Pharmacosmos Therapeutics Inc. | Advisor | 2022 - Present |
Deutsche Forschungsgemeinschaft (DFG) | Ad-hoc Member | 2021 - Present |
French National Research Agency | Ad-hoc reviewer | 2021 - Present |
PRMRP Musculoskeletal health (PRE-MSH-1), Department of Defense | Ad-hoc Member | 2020 - Present |
Research & Development, Pharmaceuticals Pediatric Development, Bayer AG, Berlin, Germany | Advisor | 2020 - Present |
Nature Scientific Reports | Guest Editor | 2019 - 2021 |
Skeletal Biology Development and Disease (SBDD), NIH | Ad-hoc Member | 2017 - Present |
Association of Osteobiology | Member | 2016 - Present |
Advances in Mineral Metabolism (AIMM) | Board Member | 2016 - Present |
American Society of Bone and Mineral Research (ASBMR) | Member | 1993 - Present |